article thumbnail

How AI will reshape pharma by 2025

Drug Target Review

Looking ahead, 2025 could represent a major turning point for the pharmaceutical sector. Their work focuses on creating ‘digital twin generators’ – AI-driven models that predict how a patients disease may progress over time. Approaches that improve data efficiency will drive this space, Smith explains.

article thumbnail

Alzheimer’s Drug, Leqembi, Can Be Safely Administered In Memory Clinics, Study Says

Drugs.com

THURSDAY, May 15, 2025 — The 2023 approval of the first drug shown to slow the progression of Alzheimer’s disease came with no small amount of concern from skeptics. Lecanemab (Leqembi) modestly slows Alzheimer’s by helping the.

Drugs 275
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ozempic Can Treat Fatty Liver Disease

Drugs.com

THURSDAY, May 1, 2025 -- The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has found.Nearly twice as many people taking semaglutide stopped their fatty liver disease without further.

Disease 277
article thumbnail

Researchers devise new way to target and correct disease-related proteins

Broad Institute

By Leah Eisenstadt January 6, 2025 Credit: Courtesy of the Xavier and Schreiber labs. Related groups Xavier lab Over the past two decades, large genetic studies have linked tens of thousands of DNA variants to thousands of human traits and diseases. The new work appears in Cell Chemical Biology.

Disease 139
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

Navigating the AI Landscape 🤖 Explore the opportunities and challenges with integrating AI in healthcare and disease prevention. 📆 May 14th, 2025 at 9:30 AM PDT, 12:30 PM EDT, 5:30 PM BST Register today to save your seat!

article thumbnail

Xenon gas could protect against Alzheimer's disease: Mouse study

Science Daily: Pharmacology News

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a novel -- and noble -- approach: using Xenon gas. A phase 1 clinical trial of the treatment in healthy volunteers will begin in early 2025.

Disease 300
article thumbnail

New Blood Test Can Diagnose, Track Alzheimer’s Disease

Drugs.com

FRIDAY, April 4, 2025 -- An experimental blood test for Alzheimers disease not only can aid in its diagnosis but also indicate how far the brain condition has progressed, a new study says.The test tracks levels of a protein called MTBR-tau243, w.

Disease 276